PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, éligible PEA-PME), une société biopharmaceutique dédiée au développement et à la commercialisation des thérapies géniques innovantes pour le traitement de…
Author: Business Wire
GenSight Biologics Announces Positive Data Safety Monitoring Board Review of PIONEER Phase I/II Clinical Trial of GS030 as Optogenetic Treatment for Retinitis Pigmentosa
PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and cent…
Luminopia One, a Digital Therapeutic for Amblyopia, Demonstrates Safety and Efficacy in Phase 3 Pivotal Trial
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Luminopia today announced the publication of positive Phase 3 pivotal data of its investigational treatment for amblyopia—Luminopia OneTM—in OphthalmologyⓇ, the journal of the American Academy of Ophthalmology. This i…
Aurion Biotech Announces Strategic Investments in Manufacturing
SEATTLE & BOSTON & TOKYO–(BUSINESS WIRE)–Aurion Biotech Makes Strategic Investments in Cell Therapy Production, Appoints Tim Largen VP Manufacturing
Visus Therapeutics Hosts Inaugural Capital Markets Day in New York City
SEATTLE–(BUSINESS WIRE)–Visus Therapeutics Inc., a clinical-stage pharmaceutical company focused on developing innovative ophthalmic therapies to improve vision for people around the world, recently welcomed investors, analysts and media to its inaug…
Global Ophthalmic Drug Delivery Devices Market (2021 to 2030) – Focus on Product, Formulation, Sales Channel, End-user and Region – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Ophthalmic Drug Delivery Devices Market: Focus on Product, Formulation, Sales Channel, End User, and 21 Countries – Analysis and Forecast, 2021-2030” report has been added to ResearchAndMarkets.com’s offering. The g…
Global Age-Related Macular Degeneration Markets and Competitive Landscape Report 2021 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Age-Related Macular Degeneration Market and Competitive Landscape – 2021” report has been added to ResearchAndMarkets.com’s offering. Global Age-Related Macular Degeneration Market and Competitive Landscape – 2021, …
Uveitis Drug Pipeline Landscape Research Report 2021 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Uveitis (Ophthalmology) – Drugs In Development, 2021” report has been added to ResearchAndMarkets.com’s offering. Uveitis – Drugs In Development, 2021, provides an overview of the Uveitis (Ophthalmology) pipeline landscape…
Global Refractive Surgery Devices Market (2021 to 2028) – Size, Share & Trends Analysis Report – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Refractive Surgery Devices Market Size, Share & Trends Analysis Report by Application (Myopia, Astigmatism), by Product (Lasers, Aberrometers), by End Use (Hospitals, Ambulatory Surgery Centers), and Segment For…
VisualCamp Chosen as Representative Korean Startup at TechCrunch Disrupt 2021
SEOUL, South Korea–(BUSINESS WIRE)– #2021SLINGSHOTTop500GlobalStartups–VisualCamp was selected to represent one of Korea’s pioneering startups at TechCrunch Disrupt 2021, thanks to its AI-based eye tracking SDK, SeeSo.
Soleo Health Unveils Therapeutic Care Management Center Dedicated to Thyroid Eye Disease Patients
FRISCO, Texas–(BUSINESS WIRE)– #SoleoHealthTCMC–SOLEO HEALTH UNVEILS THERAPEUTIC CARE MANAGEMENT CENTER DEDICATED TO THYROID EYE DISEASE PATIENTS
Opregen® Data Update Will Be Featured at 54th Annual Retina Society Meeting in Podium Presentation by Christopher D. Riemann, M.D.
CARLSBAD, Calif.–(BUSINESS WIRE)—- $LCTX #LineageCellTherapeutics–Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, reported today th…
Ocular Therapeutix™ Updates Monthly In-Market Unit Sales of DEXTENZA® Billable Inserts
BEDFORD, Mass.–(BUSINESS WIRE)—- $OCUL #OCUTX–Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today r…
Aerie Pharmaceuticals Announces Appointment of Carolyn McAuliffe, Senior Director, Communications
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucom…
Gemini Therapeutics Announces Presentation of Preclinical Data at the 13th International Conference on Complement Therapeutics
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Gemini Therapeutics, Inc. (Nasdaq: GMTX), a clinical stage precision medicine company developing innovative treatments for genetically defined age-related macular degeneration (AMD), today announced one oral presentat…
Insights on the Ophthalmic Instrumentation Global Market to 2027 – Featuring Kowa, Leica Microsystems and Nidek Among Others – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Ophthalmic Instrumentation – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering. Amid the COVID-19 crisis, the global market for Ophthalmic Instrumentation estimated at US$…
EyeSouth Partners Affiliates With Eye Center of St. Augustine, Representing the Network’s 25th Affiliation and Sixth Practice in Florida
ATLANTA–(BUSINESS WIRE)–EyeSouth Partners (“EyeSouth” or the “Company”) is pleased to announce that it has completed an affiliation with Eye Center of St. Augustine (“ECSA”). The affiliation represents EyeSouth’s sixth in the state of Florida and twe…
Global Dry Eye Markets and Competitive Landscape Report 2021 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Dry Eye Market and Competitive Landscape – 2021” report has been added to ResearchAndMarkets.com’s offering. The report provides comprehensive insights into Dry Eye pipeline, epidemiology, market valuations, drug sa…
Ophthalmology Drug Pipeline Database 2021 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Ophthalmology Pipeline Database – 2021” report has been added to ResearchAndMarkets.com’s offering. Ophthalmology Pipeline Highlights Database – 2021, provides the most up-to-date information on key pipeline products in th…
Retinopathy Of Prematurity (Ophthalmology) Drugs Pipeline Report 2021 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Retinopathy Of Prematurity (Ophthalmology) – Drugs In Development, 2021” report has been added to ResearchAndMarkets.com’s offering. The report provides an overview of the Retinopathy Of Prematurity (Ophthalmology) pipelin…